PlainRecalls

Bionpharma Inc.

Compiled from official public sources by the publisher.

3 recalls on record · Latest: Jul 29, 2026

Subscribe to new Bionpharma Inc. recalls (RSS)

Agency notice ledger

Federal filing book Bionpharma Inc. LIGHT-BOOK · SINGLE-AGENCY

#3,410 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #3,410 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Drug (3)
  • CAT children
  • CATS 2 categories
  • LATEST Jul 29, 2026
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

Bionpharma Inc. accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Bionpharma Inc. compares to 14,151 recalling firms

Bionpharma Inc. ranks 3,410th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Bionpharma Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 3410th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Bionpharma Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Bionpharma Inc. holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jul 29, 2026

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
FDA Drug Critical Oct 23, 2024

Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
FDA Drug Moderate Jul 31, 2019

Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bionpharma Inc., 600 Alexander Road, Princeton, NJ 08540, NDC 69452-116-45.

Bionpharma Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar children volume

Nearest multi-notice firms that share this firm's dominant product category.

Actavis South Atlantic LLC 3 Amazon.com, Inc. 3 B @ B Trade Inc. 3 Baby Jogger LLC, of Richmond, Va. 3

Frequently Asked Questions

How many federal recall notices name Bionpharma Inc.? ▼
PlainRecalls indexes 3 distinct federal recall events naming Bionpharma Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Bionpharma Inc. sit among other recalling firms? ▼
Bionpharma Inc. ranks #3,410 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Bionpharma Inc.'s notices? ▼
FDA Drug accounts for 3 of this firm's 3 indexed notices.
What product category dominates Bionpharma Inc.'s filing book? ▼
Filings for Bionpharma Inc. span 2 product categories, led by children. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Bionpharma Inc.: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Bionpharma Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026